Gilles Darcis

University of Liège — Belgium

Immunology and Microbiology · Life Sciences

29h-index3.9kcitations155works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(65), HIV/AIDS drug development and treatment(43), HIV/AIDS Research and Interventions(42), SARS-CoV-2 and COVID-19 Research(27), HIV-related health complications and treatments(20)

Publications150 total

Safety and efficacy of an outpatient parenteral antimicrobial therapy program at a tertiary hospital in Belgium: a monocentric retrospective observational study
Acta Clinica Belgica·2025Open Access
COVID-19 vaccination: Does knowledge of higher immunity influence first and second COVID-19 booster uptake? A study carried out in a university population
Vaccine·2025Open Access
Reply to Satapathy et al.'s comment on “Dual cross‐sectional and longitudinal perspective on the continuum of <scp>HIV</scp> care to disentangle natural epidemic evolution from real progress, Belgium 2014–2022”
HIV Medicine·2025Open Access
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
2025Open Access
Author response: Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
2025Open Access
Personalized prediction of SARS-CoV-2 vaccine-induced immunity after boost: a longitudinal analysis using joint modeling
Frontiers in Immunology·2025Open Access
Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium
Frontiers in Pharmacology·2025Open Access
Tick-Borne Encephalitis Serological Survey of Students from University of Liège
Viruses·2025Open Access
Factors Contributing to Pneumococcal, COVID-19, and Influenza Vaccine Uptake Among People Living With HIV in Belgium: A Retrospective Study
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Postoperative hip arthroplasty infections: A monocentric retrospective study in Liège University Hospital, Belgium, 2015-2023
CMI Communications·2025Open Access
No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals
Frontiers in Immunology·2025· 2 citedOpen Access
Pure CD32+ CD4+ Cells Are Cytotoxic Memory CD4+ T Lymphocytes Highly Enriched for HIV-1 DNA
2025· 1 citedOpen Access
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
2025· 1 citedOpen Access
Author response: Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
2025Open Access
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
eLife·2025Open Access
Removing barriers to COVID-19 vaccine intention in a university population: Results of a serial mediation study through the dimensions of the Health Belief Model
PLoS ONE·2025· 1 citedOpen Access
Dual cross‐sectional and longitudinal perspective on the continuum of <scp>HIV</scp> care to disentangle natural epidemic evolution from real progress, Belgium 2014–2022
HIV Medicine·2025· 2 citedOpen Access
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
2025Open Access
Development and multicentric external validation of a prognostic COVID-19 severity model based on thoracic CT
BMC Medical Informatics and Decision Making·2025Open Access
West Nile and Usutu viruses: current spreading and future threats in a warming northern Europe
Frontiers in Virology·2025· 4 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Michel Moutschen(22), Carine Van Lint(14), Christelle Meuris(11), Philippe Léonard(9), Ben Berkhout(8), Sophie Bouchat(7), Anne-Sophie Sauvage(7), Nathalie Maes(7), Alexander Pasternak(7), Marie‐Pierre Hayette(7), Karine Fombellida(7), Anna Kula(6), Benoît Van Driessche(6), Olivier Rohr(6), Frédéric Frippiat(6), Majdouline El Moussaoui(6), Dolorès Vaira(6), Nadège Delacourt(5), Caroline Vanhulle(5), Christine Rouzioux(5)